Found: 23
Select item for more details and to access through your institution.
Phospho-PR Isoforms and Cancer Stem Cells: What Does the FOXO1 Say?
- Published in:
- Endocrinology, 2019, v. 160, n. 5, p. 1067, doi. 10.1210/en.2019-00158
- By:
- Publication type:
- Article
3300 Progesterone receptor alters lipid biology in luminal breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p.
- Published in:
- Nature Communications, 2015, v. 6, n. 12, p. 10077, doi. 10.1038/ncomms10077
- By:
- Publication type:
- Article
Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
New generation breast cancer cell lines developed from patient-derived xenografts.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Separation of breast cancer and organ microenvironment transcriptomes in metastases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cover Image, Volume 61, Issue 3.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 3, p. i, doi. 10.1002/mc.23397
- By:
- Publication type:
- Article
Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor‐positive breast cancer.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 3, p. 359, doi. 10.1002/mc.23377
- By:
- Publication type:
- Article
Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 10, p. 1129, doi. 10.1002/mc.23242
- By:
- Publication type:
- Article
Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors.
- Published in:
- Breast Cancer Research, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13058-022-01585-1
- By:
- Publication type:
- Article
Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment.
- Published in:
- Journal of Mammary Gland Biology & Neoplasia, 2021, v. 26, n. 4, p. 399, doi. 10.1007/s10911-021-09505-3
- By:
- Publication type:
- Article
Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells.
- Published in:
- Journal of Mammary Gland Biology & Neoplasia, 2015, v. 20, n. 1/2, p. 39, doi. 10.1007/s10911-015-9340-5
- By:
- Publication type:
- Article
Preface.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29498-9
- By:
- Publication type:
- Article
Recovery and analysis of transcriptome subsets from pooled single-cell RNA-seq libraries.
- Published in:
- Nucleic Acids Research, 2019, v. 47, n. 4, p. e20, doi. 10.1093/nar/gky1204
- By:
- Publication type:
- Article
Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3179, doi. 10.3390/cancers15123179
- By:
- Publication type:
- Article
Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1776, doi. 10.3390/cancers14071776
- By:
- Publication type:
- Article
The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 135, n. 2, p. 415, doi. 10.1007/s10549-012-2164-8
- By:
- Publication type:
- Article
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 128, n. 1, p. 45, doi. 10.1007/s10549-010-1078-6
- By:
- Publication type:
- Article
Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 9, p. 1481, doi. 10.1002/ijc.33913
- By:
- Publication type:
- Article